NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial

OBJECTIVE: To investigate the efficacy and safety of MLC901 in vascular cognitive impairment no dementia (VCIND) patients. DESIGN: This was a multi‐center, double‐blind, randomized, placebo‐controlled pilot study. SETTING AND PARTICIPANT: VCIND patients from hospitals in Singapore (67), Vietnam (19)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Christopher L. H., Nguyen, Trọng Hung, Marasigan, Simeon, Lee, Chun Fan, Lu, Qingshu, Kandiah, Nagaendran, de Silva, Deidre, Chong, Eddie, Venketasubramanian, Narayanaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010368/
https://www.ncbi.nlm.nih.gov/pubmed/33816765
http://dx.doi.org/10.1002/trc2.12161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010368/
https://www.ncbi.nlm.nih.gov/pubmed/33816765
http://dx.doi.org/10.1002/trc2.12161

Ejemplares similares